CEBPD and glioblastoma: The increased expression of CEBPD protein levels in GBMs was confirmed by performing immunohistochemistry (IHC) in a tissue chip, including 5 normal brain samples, 30 grade II A, 20 grade III AA, and 50 GBM samples, and the IHC intensity was semi-quantified (Fig. 2D).